PFS Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.37K | Hold |
14
| – | – | ﹤0.01% | 350 |
|
|
2025
Q1 | $8.89K | Hold |
14
| – | – | ﹤0.01% | 297 |
|
|
2024
Q4 | $9.97K | Hold |
14
| – | – | 0.01% | 287 |
|
|
2024
Q3 | $14.7K | Hold |
14
| – | – | 0.01% | 245 |
|
|
2024
Q2 | $14.7K | Hold |
14
| – | – | 0.01% | 227 |
|
|
2024
Q1 | $13.5K | Hold |
14
| – | – | 0.01% | 241 |
|
|
2023
Q4 | $12.3K | Hold |
14
| – | – | 0.01% | 246 |
|
|
2023
Q3 | $11.5K | Hold |
14
| – | – | 0.01% | 231 |
|
|
2023
Q2 | $10.1K | Buy |
+14
| New | +$10.1K | 0.01% | 264 |
|